Evidence map›Paper›PMID 39544306›Full record

ArticleFrontiers in oncology2024

Comparative prediction of lymph node metastasis in pT1 colorectal cancer among Western and Japanese guidelines.

Fumiaki Tanino, Ken Yamashita, Shin Morimoto, Yudai Takehara, Noriko Yamamoto, Yuki Kamigaichi, Tomoyuki Nishimura, Hidenori Tanaka, Hidehiko Takigawa, Yuji Urabe and 3 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Fumiaki TaninoDepartment of Gastroenterology, Hiroshima University, Hiroshima, Japan.
Ken YamashitaDepartment of Gastroenterology, Hiroshima University, Hiroshima, Japan.
Shin MorimotoDepartment of Gastroenterology, Hiroshima University, Hiroshima, Japan.
Yudai TakeharaDepartment of Gastroenterology, Hiroshima University, Hiroshima, Japan.
Noriko YamamotoDepartment of Gastroenterology, Hiroshima University, Hiroshima, Japan.
Yuki KamigaichiDepartment of Gastroenterology, Hiroshima University, Hiroshima, Japan.
Tomoyuki NishimuraDepartment of Gastroenterology, Hiroshima University, Hiroshima, Japan.
Hidenori TanakaDepartment of Gastroenterology, Hiroshima University, Hiroshima, Japan.
Hidehiko TakigawaDepartment of Gastroenterology, Hiroshima University, Hiroshima, Japan.
Yuji UrabeDepartment of Gastroenterology, Hiroshima University, Hiroshima, Japan.
Toshio KuwaiDepartment of Gastrointestinal Endoscopy and Medicine, Hiroshima University, Hiroshima, Japan.
Fumio ShimamotoDepartment of Health Sciences, Hiroshima Cosmopolitan University, Hiroshima, Japan.
Shiro OkaDepartment of Gastroenterology, Hiroshima University, Hiroshima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Additional surgery with lymph node (LN) dissection is recommended for pT1 colorectal carcinoma (CRC) resected by endoscopy, based on pathological risk factors for LN metastasis (LNM), according to guidelines by the Japanese Society for Cancer of the Colon and Rectum (JSCCR), National Comprehensive Cancer Network (NCCN), and European Society for Medical Oncology (ESMO). Methods: We retrospectively analyzed 560 consecutive patients with T1 CRC who underwent endoscopic resection alone (n=190) or initial or additional surgery with LN dissection (n=370) between 1992 and 2017 at Hiroshima University Hospital. Patients were classified into LNM low- and high-risk groups according to guidelines by the JSCCR, NCCN, and ESMO as follows. Patients without any specified pathological LNM risk factor were included in the LNM low-risk group, while the high-risk group comprised all other patients. We analyzed the LNM predictive ability of each guideline. Results: The LNM high-risk rate, sensitivity, specificity, positive and negative predictive values, accuracy of LNM risk, and AUC for LNM predictive ability were 82%, 100%, 19%, 9%, 100%, 26% and 0.596 in the JSCCR guidelines; 52%, 98%, 52%, 15%, 99%, 56%, and 0.749 in the NCCN; and 54%, 98%, 50%, 15%, 99%, 54%, and 0.743 in the ESMO, respectively. Conclusions: The JSCCR guidelines could diagnose LNM in all cases but had the highest false-positive rate. It is important to reduce unnecessary additional surgeries for pT1 CRCs after ER.

Indexed as

colorectal cancerendoscopic resectionguidelinelymph node metastasisT1

Identifiers

PMID39544306
PMCPMC11560900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.